Results 41 to 50 of about 7,176,980 (297)

Early Onset Outlet Obstruction of a Temporary Diverting Loop Ileostomy Secondary to Urinary Retention

Case Reports in Gastroenterology, 2023
A mechanical obstruction is not a physiological entity, and when it occurs within the 30-day postoperative period, it is called an early postoperative small bowel obstruction.
Umut Akova, Volkan Dogru, Eren Esen, Feza Remzi   +3 more
doaj   +1 more source

Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management

Gastroenterology, 2021
Inflammatory bowel diseases (IBD) are systemic disease that manifest not only in the gut/GI tract but also in many patients in extraintestinal organs.
G. Rogler, A. Singh, A. Kavanaugh, D. Rubin   +3 more
semanticscholar   +1 more source

Have advances in medical therapy for ulcerative colitis impacted surgical treatment?

Annals of Gastroenterological Surgery, 2023
Aim The purpose of this study was to examine how the clinical characteristics, indications for surgery, and postoperative course of ulcerative colitis (UC) surgical patients changed before and after the introduction of biological agents. Methods Patients
Ryuichi Kuwahara, Hiroki Ikeuchi, Yuki Horio, Tomohiro Minagawa, Kurando Kusunoki, Motoi Uchino   +5 more
doaj   +1 more source

Gut microbiome structure and metabolic activity in inflammatory bowel disease

Nature Microbiology, 2018
The inflammatory bowel diseases (IBDs), which include Crohn’s disease (CD) and ulcerative colitis (UC), are multifactorial chronic conditions of the gastrointestinal tract.
E. Franzosa, Alexandra Sirota-Madi, J. Ávila-Pacheco, Nadine Fornelos, H. J. Haiser, S. Reinker, T. Vatanen, A. B. Hall, Himel Mallick, L. McIver, J. Sauk, R. Wilson, B. Stevens, J. Scott, K. Pierce, A. Deik, K. Bullock, F. Imhann, Jeffrey A. Porter, A. Zhernakova, Jing-Yuan Fu, R. Weersma, C. Wijmenga, C. Clish, H. Vlamakis, C. Huttenhower, R. Xavier   +26 more
semanticscholar   +1 more source

Macrophage polarization in inflammatory bowel disease

Cell Communication and Signaling, 2023
The growing prevalence of inflammatory bowel disease (IBD) has encouraged research efforts, which have contributed to gradual improvements in our understanding of IBD diagnosis and therapeutic approaches.
Kun Zhang, Jing Guo, Wenlong Yan, Ling-Fen Xu   +3 more
semanticscholar   +1 more source

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations

Nature Genetics, 2015
Ulcerative colitis and Crohn's disease are the two main forms of inflammatory bowel disease (IBD). Here we report the first trans-ancestry association study of IBD, with genome-wide or Immunochip genotype data from an extended cohort of 86,640 European ...
Jimmy Z. Liu, S. van Sommeren, Hai-Liang Huang, S. Ng, R. Alberts, A. Takahashi, S. Ripke, James C. Lee, L. Jostins, Tejas Shah, S. Abedian, J. Cheon, Judy H. Cho, Naser E. Dayani, L. Franke, Y. Fuyuno, A. Hart, R. Juyal, G. Juyal, W. Kim, A. Morris, H. Poustchi, W. Newman, V. Midha, T. Orchard, H. Vahedi, A. Sood, J. Sung, R. Malekzadeh, H. Westra, K. Yamazaki, Suk-Kyun Yang, J. Barrett, B. Alizadeh, M. Parkes, Thelma Bk, M. Daly, M. Kubo, C. Anderson, R. Weersma   +39 more
semanticscholar   +1 more source

The Gut Microbiota in Inflammatory Bowel Disease

Frontiers in Cellular and Infection Microbiology, 2022
Epidemiological surveys indicate that the incidence of inflammatory bowel disease (IBD) is increasing rapidly with the continuous growth of the economy.
Peng Qiu, T. Ishimoto, Ling-Feng Fu, Jun Zhang, Zhen-Yong Zhang, Yang Liu   +5 more
semanticscholar   +1 more source

Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) [PDF]

Background: The utilization of anti-tumor necrosis factor-alpha (anti-TNF-alpha) biosimilars in inflammatory bowel disease (IBD) is constantly increasing. However, pediatric data are limited.
Francesco Graziano, Citrano, Michele, Orlando, Ambrogio, Pellegrino, Salvatore, Marco Ventimiglia, Sicilian Network For Inflammatory Bowel Disease, null, Dipasquale, Valeria, Cappello, Maria, Romano, Claudio, Anita Busacca, Ventimiglia, Marco, Graziano, Francesco, Valeria Dipasquale, Michele Citrano, Salvatore Pellegrino, Claudio Romano, Salvatore Accomando, Accomando, Salvatore, Maria Cappello, Busacca, Anita, Sicilian Network for Inflammatory Bowel Disease Sicilian Network for Inflammatory Bowel Disease, Ambrogio Orlando   +21 more
core   +1 more source

Review of the safety with biologics in inflammatory bowel disease

Journal of IMIDs, 2022
Biologics have completely changed the treatment (and life) of patients with inflammatory bowel disease (IBD). After the first ones, anti-tumor necrosis factor (TNF) biologics, two new biologics, with other therapeutic targets, are now in routine use in ...
Andrea Pascual, Raquel Vicente, Eva Sierra, Santiago García-López   +3 more
doaj   +1 more source

Management of Anal Fistula with Crohn's Disease

Journal of the Anus, Rectum and Colon
Crohn's disease (CD) causes gastrointestinal symptoms (i.e., diarrhea and abdominal pain), systemic symptoms (i.e., fatigue, anemia, weight loss, and fever), and perianal fistulas that produce anal pain. Because of the frequent occurrence of diarrhea and
Shota Takano, Yasushi Nakamura, Kohei Tamaoka, Takafumi Yoshimoto, Yasue Irei, Yoriyuki Tsuji   +5 more
doaj   +1 more source